RIX4414 vaccine: all 32 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy InfantsCompletedNCT02907216Phase 4Results posted
• Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot StudyCompletedNCT02542462Phase 4Results posted
• Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural GhanaCompletedNCT01575197Phase 4Results posted
• Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in BangladeshCompletedNCT01375647Phase 3Results posted
• Safety and Immunogenicity of Sequential Rotavirus Vaccine SchedulesCompletedNCT01266850Phase 4Results posted
• Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean InfantsCompletedNCT00969228Phase 4Results posted
• Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of AgeCompletedNCT00533507Phase 3Results posted
• Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of AgeCompletedNCT00489554Phase 3Results posted
• Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese InfantsCompletedNCT00480324Phase 3Results posted
• A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.CompletedNCT00432380Phase 2Results posted
• To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term InfantsCompletedNCT00420745Phase 3Results posted
• Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine.CompletedNCT00420316Phase 3Results posted
• A Study to Explore the Existence of Horizontal Transmission of the RIX4414 Vaccine Strain Between Twins Within a Family.CompletedNCT00396630Phase 3Results posted
• Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)CompletedNCT00329745Phase 3Results posted
• A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South AfricaCompletedNCT00263666Phase 2Results posted
• Vaccine Efficacy Against Rotavirus Diarrhea; Vaccine Given With Routine Childhood Vaccinations in Healthy African InfantsCompletedNCT00241644Phase 3Results posted
• Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to InfantsCompletedNCT00158756Phase 3Results posted
• Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in AfricaCompletedNCT04658914Phase 2
• Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus VaccineCompletedNCT04344054Phase 2
• Optimising Rotavirus Vaccine in Aboriginal ChildrenActive, not recruitingNCT02941107Phase 4
• Randomized, Controlled Single-blind Clinical Study to Assess Vaccine Interchangeability Between RV5 and RV1 Using Seven Combined Anti-rotavirus Prevention ProgramsCompletedNCT02193061Phase 3
• A Dose-escalating Study to Evaluate the Immunogenicity and Safety of Rotavin-M1 Vaccine in Healthy InfantsCompletedNCT01377571Phase 2
• Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese AdultsCompletedNCT01162590Phase 1
• Study to Evaluate the Safety of Rotarix™ in Chinese ChildrenCompletedNCT01086436Phase 1
• Pilot Study of the Rotavirus Vaccine in Infants With Intestinal FailureCompletedNCT00995813Phase 4
• Assessment of Clinical Consistency of Three Production Lots of GSK Biologicals' HRV VaccineCompletedNCT00757770Phase 3
• Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in MatlabCompletedNCT00737503Phase 4
• Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy InfantsCompletedNCT00429481Phase 2
• Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine in Healthy InfantsCompletedNCT00425737Phase 2
• Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 MonthsCompletedNCT00385320Phase 2
• Evaluate Safety & Immunogenicity of 2 or 3 Doses of GSK HRV Vaccine in Healthy Infants in South AfricaCompletedNCT00383903Phase 2
• Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant VaccinesCompletedNCT00370318Phase 3

← RIX4414 vaccine overview